Maverick Capital’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Hold
331,234
– – 0.03% 63
2026
Q1
$1.82M Sell
331,234
-22,807
-6% -$252K 0.02% 84
2025
Q4
$9.35M Hold
354,041
– – 0.1% 55
2025
Q3
$6.76M Hold
354,041
– – 0.09% 65
2025
Q2
$6.88M Hold
354,041
– – 0.1% 56
2025
Q1
$5.06M Hold
354,041
– – 0.09% 83
2024
Q4
$8.75M Hold
354,041
– – 0.16% 54
2024
Q3
$10.7M Sell
354,041
-515
-0.1% -$20.2K 0.21% 50
2024
Q2
$18.2M Hold
354,556
– – 0.34% 48
2024
Q1
$31.5M Buy
+354,556
New +$35.8M 0.59% 45

Other funds holding GUTS

Maverick Capital's GUTS Position: Q2 2026 in Review

Maverick Capital held its Fractyl Health (GUTS) position steady in Q2 2026 at 331,234 shares worth $3.16M. The position accounts for 0.03% of the portfolio, ranked #63.

Maverick Capital first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $31.5M in Q1 2024. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Maverick Capital held 331,234 shares of Fractyl Health worth $3.16M as of Q2 2026.
  • Maverick Capital left its Fractyl Health share count unchanged in Q2 2026.
  • Fractyl Health made up 0.03% of Maverick Capital's portfolio in Q2 2026, its #63 holding.
  • Maverick Capital first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • Maverick Capital's Fractyl Health position peaked at $31.5M in Q1 2024.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.